Along with others across the country, Ohio residents may be wondering just how many commonly and abundantly used medications will end up containing N-Nitrosodimethylamine? So far, NDMA has been found in blood pressure medications and heartburn medications. Now, the Food and Drug Administration has announced that some pharmaceutical companies are recalling lots of extended release Metformin — prescribed for type 2 diabetes — due to the presence of this same probable human carcinogen.
To date, no lots of immediate release Metformin medications have been recalled. This is said to be the most often prescribed here in the United States. At this time, the FDA does not recommend that individuals taking the recalled medications to stop taking them immediately. Instead, they urge individuals to contact their doctors first. In fact, the agency advises that medical professionals continue to prescribe this type of medication if it makes clinical sense to do so.
In the meantime, the FDA urges other companies who manufacture ER Metformin to conduct testing to determine whether NDMA is present in higher than allowed levels, which means more recalls could be coming. The hope is that issues can be detected prior to the medications finding their way to the public. In fact, if these recalls follow the same track as the ones for blood pressure and heartburn medications, Ohio residents who take any type of Metformin may want to watch for additional recalls in the future.
As the Food and Drug Administration continues to investigate the presence of NDMA in popular medications, Ohio residents may end up suffering harm due to these and other medications. The sad truth is that many recalls come too late to prevent this from happening. However, this does not preclude victims from seeking justice and restitution through the courts.
